Australian researchers close in on malaria vaccine

Australian researchers said Tuesday they were closing in on a potential vaccine against malaria, with a study showing their treatment had protected mice against several strains of the disease.

Michael Good, from Queensland's Griffith University, said the vaccine led to naturally existing white blood cells, or T-cells, attacking the potentially deadly malaria parasite which lives in .

"A single vaccination induced profound immunity to different malaria parasite species," the study, published Tuesday in the Journal of Clinical Investigation, states.

Good said the team's research was focused on inducing the white blood cells to attack the parasite, whatever the .

"The T-cells (), when they're induced to kill malaria, can recognise proteins throughout the parasite, even internal proteins in the parasite," he told the ABC.

"So that's where we think the novel aspect is: we've been able to induce a form of which can recognise molecules in the parasite which are present in every single strain."

Good said he believed it was the first time that a vaccine had been shown to protect against more that two strains of malaria in mice.

The vaccine was expected to be cheap and easy to manufacture, he added, meaning that—if applicable to humans—it could have a significant impact in poor countries where malaria kills thousands each year.

"But we don't want to get ahead of ourselves; we want to demonstrate, first and foremost, that the vaccine is effective in humans," Good told the broadcaster.

In 2010 an estimated 219 million people were infected with the disease and some 660,000 died, most of them African children aged under five, the UN's World Health Organisation said in December.

A study published in the Lancet in February 2012 said the global death toll was more likely to be around 1.2 million a year.

More information: Cross-species malaria immunity induced by chemically attenuated parasites, J Clin Invest. doi:10.1172/JCI66634

add to favorites email to friend print save as pdf

Related Stories

Malaria's severity reset by mosquito

May 30, 2013

(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

Improving human immunity to malaria

Aug 01, 2012

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells. ...

Researchers reveal malaria's deadly grip

Jun 05, 2013

Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites ...

Recommended for you

Proper stem cell function requires hydrogen sulfide

1 hour ago

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry ...

Bionic ankle 'emulates nature'

6 hours ago

These days, Hugh Herr, an associate professor of media arts and sciences at MIT, gets about 100 emails daily from people across the world interested in his bionic limbs.

Firm targets 3D printing synthetic tissues, organs

8 hours ago

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

User comments